FDA Top Scientist Goodman Prioritizes "Strengthening Our Scientific Approach"
This article was originally published in The Tan Sheet
Executive Summary
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original focus: improving the agency's scientific capacity and integrity.
You may also be interested in...
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
A $25 million, cross-center scientific modernization effort proposed in FDA's fiscal 2011 budget targets gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
A $25 million, cross-center scientific modernization effort proposed in FDA's fiscal 2011 budget targets gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
A $25 million, cross-center scientific modernization effort proposed in FDA's fiscal 2011 budget targets gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology